Prof Ed Lavelle is Professor In Immunology, member of the Royal Irish Academy and fellow of TCD. He graduated with a BSc in Microbiology from University College Galway and a PhD in Immunology from the University of Plymouth followed by postdoctoral postions at the University of Nottingham, Rowett Research Institute (Aberdeen) and Trinity College Dublin, researching vaccine adjuvants and immunomodulators.
He has been a member of the academic staff at TCD since 2004 and is a Principal Investigator in the School of Biochemistry and Immunology at Trinity College Dublin. His research focuses on the development and mode of action of vaccine adjuvants with applications across infectious diseases, cancer and inflammatory conditions. The Lavelle group works closely with a number of academic, Biotech and Pharma collaborators engaged in vaccine research.
His current work with AMBER is on how particulate biomaterials regulate innate immune responses and how the physicochemical properties of materials can be designed to control the induction of beneficial immune responses.
AMBER has a strong emphasis on collaboration. Central to AMBER’s research remit are collaborative projects performed with industry partners, and working with academic, industry and wider stakeholder on international and national research programmes.Get in touch